Analyst Insights - Digital Health Posts
Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.
Signify Premium Insight: The Enviable Problem Facing Siemens Healthineers
Signify Premium Insights Subscription Required
25th November 2021 – Siemens Healthineers has had a run of good results recently, but that has left the vendor with a problem: where can it go from here? This Premium Insight assesses its answer to this problem and delves into the detail of its New Ambition.
Digital Pathology: What Does the Future Hold?
25th November 2021 – Signify Research will be attending the 8th Digital Pathology and AI Congress: Europe at the London Heathrow Marriott Hotel on the 1st and 2nd December 2021.
Signify Premium Insight: Vendor Financials Roundup – The Health of the Imaging Sector Q3 2021
Signify Premium Insights Subscription Required
23rd November 2021 – The narratives of 2021’s third quarter are captured in vendors’ financial results. This Premium Insight identifies some of the quarter’s key trends and assesses the performance of various medical imaging and imaging IT vendors.
Signify Premium Insight: GE Healthcare’s New Beginning
Signify Premium Insights Subscription Required
18th November 2021 – GE’s decision to split into three separate companies may mark the end of the traditional industrial conglomerate, but it represents a fresh start for the firm’s Healthcare unit. Now unbound, GE Healthcare can start to deliver on its promise, the question is, where to begin?
Signify Premium Insight: DeepSight’s $25m Bill for Ultrasound Disruption
Signify Premium Insights Subscription Required
16th November 2021 – DeepSight Technology recently announced that it has secured $25m in Series A funding to develop its ultrasound technology, which is said to offer 100 times greater sensitivity than other options on the market. This Premium Insight weighs the vendor’s prospects and assesses what such technology means for the market.